Evaluation and cost estimation of laboratory test overuse in 43 commonly ordered parameters through a Computerized Clinical Decision Support System (CCDSS) in a large university hospital

Abstract

Background Computerized Clinical Decision Support Systems (CCDSS) have become increasingly important in ensuring patient safety and supporting all phases of clinical decision making. The aim of this study is to evaluate, through a CCDSS, the rate of the laboratory tests overuse and to estimate the cost of the inappropriate requests in a large university hospital. Method In this observational study, hospital physicians submitted the examination requests for the inpatients through a Computerized Physician Order Entry. Violations of the rules in tests requests were intercepted and counted by a CCDSS, over a period of 20 months. Descriptive and inferential statistics (Student’s t -test and ANOVA) were made. Finally, the monthly comprehensive cost of the laboratory tests was calculated. Results During the observation period a total of 5,716,370 requests were analyzed and 809,245 violations were counted. The global rate of overuse was 14.2% ± 3.0%. The most inappropriate exams were Alpha Fetoprotein (85.8% ± 30.5%), Chlamydia trachomatis Nucleic Acid Amplification (48.7% ± 8.8%) and Alkaline Phosphatase (20.3% ± 6.5%). The monthly cost of over-utilization was 56,534€ for basic panel, 14,421€ for coagulation, 4,758€ for microbiology, 432€ for immunology exams. All the exams, generated an estimated avoidable cost of 1,719,337€ (85,967€ per month) for the hospital. Conclusions The study confirms the wide variability in over-utilization rates of laboratory tests. For these reasons, the real impact of inappropriateness is difficult to assess, but the generated costs for patients, hospitals and health systems are certainly high and not negligible. It would be desirable for international medical communities to produce a complete panel of prescriptive rules for all the most common laboratory exams that is useful not only to reduce costs, but also to ensure standardization and high-quality care.

Impact of COVID‐19 restrictions on pathology service utilisation

“…The behaviour of not seeking treatment for urgent care conditions needs to be addressed in preparation for further possible COVID‐19 restrictions and other pandemics. Conversely, overuse of pathology testing is a known issue in healthcare services and leads to increased risk of harm to patients and contributes to overspending in the health system 16 . A systematic review of published studies on inappropriate pathology testing found an overall rate of overutilisation of testing of more than 20% 17 .…”

Rethinking Blood Testing in Pediatric Cancer Patients: A Quality Improvement Approach

“…Change ideas to limit blood requests have focused on improving knowledge, changing systems, and financial implications. [2][3][4]6,13 Wertheim et al demonstrated a reduction in blood ordering in an adult general medical service. 2 Similar to our project, change ideas included education and the development of written guidelines.…”

“…1–3 Tamburrano et al identified a consistent rise in blood tests by approximately 5% per annum over the past ten years in the United States and Europe. 4 Indeed, health economists estimate that a fifth of spending in healthcare is ineffective and even wasteful. 5…”

“…[1][2][3] Tamburrano et al identified a consistent rise in blood tests by approximately 5% per annum over the past ten years in the United States and Europe. 4 Indeed, health economists estimate that a fifth of spending in healthcare is ineffective and even wasteful. 5 Within Australia, driven by the rising demands for hospital services, blood tests, and budgetary constraints, the National Coalition of Public Pathology (NCOPP) was endorsed under the Department of Health and Ageing to undertake a review on encouraging "quality pathology ordering."…”

Hemostasis Testing in the Emergency Department: A Narrative Review

“…Nonadherence to guidelines may be due to ignorance regarding cost of the tests, uncertain diagnosis, defensive medicine practice, and the wide range of available tests. 26 These practices lead to increased hospital costs, hospital-acquired anemia, and unnecessary additional laboratory and radiological tests. 27…”